# A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

> **NCT04643457** · PHASE1,PHASE2 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 107 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** UCB9741
- **DRUG:** Intravenous Placebo
- **DRUG:** Subcutaneous Placebo

## Key facts

- **NCT ID:** NCT04643457
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-27
- **Primary completion:** 2024-04-23
- **Final completion:** 2024-06-06
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643457, "A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04643457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*